NICE – UK issues MedTech innovation briefing on ‘Trublood®- Prostate’ for precision non-invasive prostate cancer diagnosis
Datar Cancer Genetics announced the publication of the internationally recognised MedTech Innovation Briefing (MIB) from…
Browsing: Prostate Cancer
Tool helps predicts who will respond best to targeted prostate cancer therapy
A new prognostic tool developed by researchers from the UCLA Jonsson Comprehensive Cancer Center, USA,…
New drug combination attacks prostate cancer on two fronts to keep men healthy for longer
Men with particularly aggressive prostate cancers can be treated more effectively by combining an existing…
EAU 2021: MRI can cut overdiagnoses in prostate-cancer screening by half
Most countries have not introduced nationwide prostate-cancer screening, as current methods result in overdiagnoses and…
EAU 2021: Monitoring proves better than active treatment for low-risk prostate cancer
Men over 60 with low-risk prostate cancer could spend ten years with no active treatment,…
AI spots prostate cancer before symptoms present
Prostate cancer is the most diagnosed cancer and a leading cause of death by cancer…
Anti-androgen therapy can fuel spread of bone tumours in advanced prostate cancer
Anti-androgen therapy is commonly used to treat patients with advanced prostate cancer at stages where…
Multimodality care improves treatment outcomes for aggressive prostate cancer
Men with high-risk prostate cancer with at least one additional aggressive feature have the best…
Immunotherapy may be effective for subset of prostate cancer
In recent years, cancer immunotherapy has been effective in treating patients with immunogenic, or so-called…
Overcoming a newly recognised form of resistance to modern prostate cancer drugs
Cancer cells have an uncanny ability to evolve and adapt to overcome the treatments used…